RESEARCH FRONTIERS INC (REFR)

US7609111072 - Common Stock

1.66  -0.04 (-2.59%)

Fundamental Rating

3

REFR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 126 industry peers in the Electronic Equipment, Instruments & Components industry. No worries on liquidiy or solvency for REFR as it has an excellent financial health rating, but there are worries on the profitability. REFR is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

REFR had negative earnings in the past year.
In the past year REFR has reported a negative cash flow from operations.
REFR had negative earnings in each of the past 5 years.
REFR had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

REFR's Return On Assets of -39.46% is on the low side compared to the rest of the industry. REFR is outperformed by 80.99% of its industry peers.
REFR's Return On Equity of -41.92% is on the low side compared to the rest of the industry. REFR is outperformed by 77.69% of its industry peers.
Industry RankSector Rank
ROA -39.46%
ROE -41.92%
ROIC N/A
ROA(3y)-46.65%
ROA(5y)-44.76%
ROE(3y)-52.94%
ROE(5y)-51.34%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

REFR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

REFR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, REFR has more shares outstanding
The number of shares outstanding for REFR has been increased compared to 5 years ago.
There is no outstanding debt for REFR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

REFR has an Altman-Z score of 131.38. This indicates that REFR is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 131.38, REFR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
There is no outstanding debt for REFR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 131.38
ROIC/WACCN/A
WACC10.31%

2.3 Liquidity

REFR has a Current Ratio of 16.19. This indicates that REFR is financially healthy and has no problem in meeting its short term obligations.
REFR has a better Current ratio (16.19) than 97.52% of its industry peers.
REFR has a Quick Ratio of 16.19. This indicates that REFR is financially healthy and has no problem in meeting its short term obligations.
REFR's Quick ratio of 16.19 is amongst the best of the industry. REFR outperforms 97.52% of its industry peers.
Industry RankSector Rank
Current Ratio 16.19
Quick Ratio 16.19

1

3. Growth

3.1 Past

REFR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.36%, which is quite impressive.
The Revenue has grown by 101.32% in the past year. This is a very strong growth!
Measured over the past years, REFR shows a decrease in Revenue. The Revenue has been decreasing by -9.40% on average per year.
EPS 1Y (TTM)29.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.2%
Revenue 1Y (TTM)101.32%
Revenue growth 3Y3.1%
Revenue growth 5Y-9.4%
Sales Q2Q%118.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

REFR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

REFR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

RESEARCH FRONTIERS INC

NASDAQ:REFR (1/3/2025, 8:00:01 PM)

1.66

-0.04 (-2.59%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)03-05 2025-03-05
Inst Owners12.65%
Inst Owner Change-22.08%
Ins Owners12%
Ins Owner Change0%
Market Cap55.64M
Analysts82.86
Price TargetN/A
Short Float %1.16%
Short Ratio11.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 37.86
P/FCF N/A
P/OCF N/A
P/B 19.71
P/tB 19.71
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.04
BVpS0.08
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.46%
ROE -41.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-46.65%
ROA(5y)-44.76%
ROE(3y)-52.94%
ROE(5y)-51.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.54%
Cap/Sales 0.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.19
Quick Ratio 16.19
Altman-Z 131.38
F-Score5
WACC10.31%
ROIC/WACCN/A
Cap/Depr(3y)1.9%
Cap/Depr(5y)25.28%
Cap/Sales(3y)0.06%
Cap/Sales(5y)2.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)101.32%
Revenue growth 3Y3.1%
Revenue growth 5Y-9.4%
Sales Q2Q%118.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.91%
OCF growth 3YN/A
OCF growth 5YN/A